APA (7th ed.) Citation

Reustle, A., Menig, L., Leuthold, P., Hofmann, U., Stühler, V., Schmees, C., . . . Schaeffeler, E. (2022). Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Clinical and translational medicine, 12(6), e883-n/a. https://doi.org/10.1002/ctm2.883

Chicago Style (17th ed.) Citation

Reustle, Anna, et al. "Nicotinamide‐N‐methyltransferase Is a Promising Metabolic Drug Target for Primary and Metastatic Clear Cell Renal Cell Carcinoma." Clinical and Translational Medicine 12, no. 6 (2022): e883-n/a. https://doi.org/10.1002/ctm2.883.

MLA (9th ed.) Citation

Reustle, Anna, et al. "Nicotinamide‐N‐methyltransferase Is a Promising Metabolic Drug Target for Primary and Metastatic Clear Cell Renal Cell Carcinoma." Clinical and Translational Medicine, vol. 12, no. 6, 2022, pp. e883-n/a, https://doi.org/10.1002/ctm2.883.